Contribution: Industrial Research Assistance Program – Contributions to Firms
Kisoji Biotechnologie Inc.
$350,000.00
Development of novel single domain antibodies for cancer therapy II
EF 2018-19 · 2018-11-01
Résumé
Cancer remains a very important disease in North America and the world. Antibodies have emerged as an effective treatment for cancer. KisoJi is developing antibodies for treatment of newly diagnosed cancers and for previously treated cancers.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Laval|Laval, Quebec, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
858257454
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2019-11-01
Agreement Number
916018
Agreement Start Date
2018-11-01
Agreement Title
Development of novel single domain antibodies for cancer therapy II
Agreement Title (French)
Développement de nouveaux anticorps à un seul domaine pour le traitement du cancer II
Agreement Type
Contribution
Agreement Value
$350,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Cancer remains a very important disease in North America and the world. Antibodies have emerged as an effective treatment for cancer. KisoJi is developing antibodies for treatment of newly diagnosed cancers and for previously treated cancers.
Description (French)
Développement de nouveaux anticorps à un seul domaine pour le traitement du cancer II
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vimy
Federal Riding (French)
Vimy
Federal Riding Number
24078
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
858257454
Recipient City
Laval|Laval
Recipient Country
CA
Recipient Legal Name
Kisoji Biotechnologie Inc.
Recipient Postal Code
H7V 3S8
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2018-2019-Q3-916018
